Jessica Tsai, MD

Internal Medicine Resident | #ValvularHeartDisease Research @MayoClinicCV 🫀 | MD 🩺

[Mayo Clinic CV @MayoClinicCV]

Research from Mayo Clinic fellows Dr. Aditi Rao and Jessica Tsai at ASE includes comparison of echo and MRI for aortic regurgitation and a pressure-adjusted heart rate index for aortic stenosis—reflecting integrated practice, research, and education. #ASE

[Jessica Tsai, MD @JessicaTsai154]

Honored to see our work featured by @JCM_MDPI

In asymptomatic aortic regurgitation, timing is everything. We review evolving imaging markers and contemporary strategies to refine risk stratification and guide intervention

[JCM MDPI @JCM_MDPI]

#mdpijcm
🩺Don't miss this new #Review
Asymptomatic #AorticRegurgitation: Evolving Imaging Markers and Contemporary Intervention Strategies
🎯https://t.co/LLNRyF1KvV
@MediPharma_MDPI
#cardiac_magnetic_resonance; #multimodal_imaging

[Mayo Clinic CV @MayoClinicCV]

A visionary researcher, dedicated mentor and global leader in cardiovascular medicine, Dr. Amir Lerman’s work reshaped how we understand and treat heart disease. His legacy will endure for generations. 🔗 https://t.co/FLqx26fXXS @MayoClinic

[Jessica Tsai, MD @JessicaTsai154]

💡Why do cardiovascular trials fail early?

Across 19,191 trials, 11.5% were terminated early, most often due to low recruitment—frequently underreported!

Improving feasibility and recruitment planning is essential for efficient clinical research.

[Frederick Berro Rivera @FredRiveraMD]

🔥 off the press

Think trials fail mostly because of safety reasons? Think again.
The #1 reason for premature termination in CV trials is low accrual!

In this article, we address the elephant in the room.

https://t.co/PZvSa9Bgdc

@MayraGuerreroMD @adnanalkhouli
@mandeep_mayo @MayoClinicCV

[Mayo Clinic CV @MayoClinicCV]

On today’s Interview w/ the Experts episode, Mayo Clinic cardiologists @DrSteveKopecky and @kylalaraMD explore how the #DietaryGuidelines translate into real-world preventive #Cardiology and patient care. Listen here: https://t.co/oTcOSyOX2G #CardioTwitter

[Jessica Tsai, MD @JessicaTsai154]

@IanCurnuttDO Thank you!

[Jessica Tsai, MD @JessicaTsai154]

New in @CircImaging with @MayoClinicCV

Discordant AS grading is common

CTA and echo often yield different AVA values because they measure different constructs — anatomic vs effective orifice area

Understanding this distinction helps integrate multimodality imaging in practice

[Mayo Clinic CV @MayoClinicCV]

New Interview w/ the Experts series starts Feb 3! What do the new #DietaryGuidelines mean for cardiometabolic health? National & #MayoClinic experts join preventative cardiologist @kylalaraMD to cut through headlines w/ evidence-based insights. Subscribe: https://t.co/6eRDgTXW4K

[Jessica Tsai, MD @JessicaTsai154]

🚨New publication in @JAHA_AHA with @MayoClinicCV

AI-ECG diastolic dysfunction predicts mortality after TAVR and enables scalable, longitudinal risk tracking beyond echo.

Grateful for the leadership Dr. Nkomo and @JaeKOh2

🔗Link to article: https://t.co/FKD6uM9j4F

[Jessica Tsai, MD @JessicaTsai154]

@SunnyWang98 @JCM_MDPI Thanks!

[Jessica Tsai, MD @JessicaTsai154]

🚨From imaging to intervention in aortic regurgitation

Our review highlights emerging imaging markers (Echo, strain, CMR) and evolving intervention strategies—repair, Ross, and TAVR.

📖Review: https://t.co/HYV2kohCIv #mdpijcm via @JCM_MDPI
#Cardiology #AorticRegurgitation

[Jessica Tsai, MD @JessicaTsai154]

@GloriaSong88 @JCM_MDPI Yes 🙌 And more to come 🔥

[Jessica Tsai, MD @JessicaTsai154]

🔥25 years of VHD trials tell:

💪Trials are becoming larger, global, and dominated by transcatheter interventions.

🚨But diversity hasn’t followed. Women remain <50% of participants, and representation varies widely by valve and modality.

Thanks for leading! @MayraGuerreroMD

[Frederick Berro Rivera @FredRiveraMD]

https://t.co/sqAvWtcFhX

Sharing our latest piece on Valve intervention trials.
Immense thanks to @MayraGuerreroMD for the support!
@mandeep_mayo @MayoCVFellows @MayoClinicCV @AbdullahAlabcha

[Jessica Tsai, MD @JessicaTsai154]

🚨 Pregnant & lactating women remain underrepresented in cardiovascular trials

Our new paper shows persistent exclusion despite growing evidence of CVD risk during pregnancy/postpartum

Inclusion is critical for evidence-based care

Thanks @DrMarthaGulati for leading this effort

[Frederick Berro Rivera @FredRiveraMD]

🔥Hot off the press🔥

Sharing our article @SpringerNature looking at enrollment of females and pregnant/lactating females in cardiovascular trials.

https://t.co/kQ7vWM7NI5

Many thanks to @DrMarthaGulati and the team for the support and guidance.

@MayoClinicCV

[Jessica Tsai, MD @JessicaTsai154]

🚨Women make up half the world—but only 41% cardiovascular trial participants

💡 Underrepresentation greatest in arrhythmia, CHD, ACS & HF
💡 Better representation in obesity, pulmonary HTN, & lifestyle trials

Barriers are systemic—requiring design, outreach, & policy solutions

[Frederick Berro Rivera @FredRiveraMD]

🔥hot off the press🔥

In this piece, we looked at the trends of participation of women in cardiovascular trials. The gap is very palpable. 🙏 @DrMarthaGulati @kylalaraMD @MayraGuerreroMD and the rest of the team for the support!
@MayoCVFellows

https://t.co/9rg0diF7qt

[Jordan Strom, MD, MSc, FACC, FASE @DocStrom]

New @ASE360 Diastology guidelines now published (https://t.co/x8lZPO5qvQ). New algorithm below, now with LARS and IVRT. Also new recs for OHT, MAC, and AF patients. Congrats @SNagueh @dysanborn and coauthors @JaeKOh2 @BonitaEcho @KristenBillick @AllanLKleinMD1 et al.

[Jessica Tsai, MD @JessicaTsai154]

You deserve it, Fred! Good luck in Rochester 🔥

[Frederick Berro Rivera @FredRiveraMD]

I am extremely honored to join @MayoClinicCV @MayoCVFellows next year as a first year cardiology fellow.
Extremely grateful to my family, mentors, and friends for all the support and prayers.

[Frederick Berro Rivera @FredRiveraMD]

#ACC25

[Jessica Tsai, MD @JessicaTsai154]

A novel marker for right and left heart coupling predicts mortality in #TAVR patients
#ACC25
Proud to represent @MayoClinicCV